Levetiracetam enhances p53-mediated MGMT inhibition and sensitizes glioblastoma cells to temozolomide
- 4 June 2010
- journal article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 12 (9), 917-927
- https://doi.org/10.1093/neuonc/noq044
Abstract
Antiepileptic drugs (AEDs) are frequently used to treat seizures in glioma patients. AEDs may have an unrecognized impact in modulating O(6)-methylguanine-DNA methyltransferase (MGMT), a DNA repair protein that has an important role in tumor cell resistance to alkylating agents. We report that levetiracetam (LEV) is the most potent MGMT inhibitor among several AEDs with diverse MGMT regulatory actions. In vitro, when used at concentrations within the human therapeutic range for seizure prophylaxis, LEV decreases MGMT protein and mRNA expression levels. Chromatin immunoprecipitation analysis reveals that LEV enhances p53 binding on the MGMT promoter by recruiting the mSin3A/histone deacetylase 1 (HDAC1) corepressor complex. However, LEV does not exert any MGMT inhibitory activity when the expression of either p53, mSin3A, or HDAC1 is abrogated. LEV inhibits malignant glioma cell proliferation and increases glioma cell sensitivity to the monofunctional alkylating agent temozolomide. In 4 newly diagnosed patients who had 2 craniotomies 7-14 days apart, prior to the initiation of any tumor-specific treatment, samples obtained before and after LEV treatment showed the inhibition of MGMT expression. Our results suggest that the choice of AED in patients with malignant gliomas may have an unrecognized impact in clinical practice and research trial design.Keywords
This publication has 32 references indexed in Scilit:
- The Unfolded Protein Response Regulator GRP78/BiP as a Novel Target for Increasing Chemosensitivity in Malignant GliomasCancer Research, 2007
- Estrogen Receptor α Inhibits p53-Mediated Transcriptional Repression: Implications for the Regulation of ApoptosisCancer Research, 2007
- Effect of Age and Comedication on Levetiracetam Pharmacokinetics and TolerabilityEpilepsia, 2007
- Properties of Antiepileptic Drugs in the Treatment of Idiopathic Generalized EpilepsiesEpilepsia, 2005
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaThe New England Journal of Medicine, 2005
- The Activity of Antiepileptic Drugs as Histone Deacetylase InhibitorsEpilepsia, 2004
- O6‐methylguanine‐DNA methyltranspherase gene expression in gliomas by means of real‐time quantitative RT‐PCR and clinical response to nitrosoureasInternational Journal of Cancer, 2002
- Increase of BCNU sensitivity by wt-p53 gene therapy in glioblastoma lines depends on the administration scheduleGene Therapy, 1999
- Contribution of O6‐methylguanine‐DNA methyltransferase to monofunctional alkylating‐agent resistance in human brain tumor—derived cell linesMolecular Carcinogenesis, 1995
- Contribution of O6‐methylguanine‐DNA methyltransferase to resistance to 1,3‐(2‐chloroethyl)‐1‐nitrosourea in human brain tumor‐derived cell linesMolecular Carcinogenesis, 1995